Operating

Net Income

Roivant Sciences Net Income decreased by 88.9% to -$313.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 365.7%, from $118.08M to -$313.70M. Over 3 years (FY 2021 to FY 2024), Net Income shows an upward trend with a -29.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

An increase indicates higher profitability and operational success, while a decrease may signal rising costs or declining sales.

Detailed definition

Net income represents the total profit of the company after all operating expenses, taxes, and interest have been deduct...

Peer comparison

Standard across all public companies, though margins vary significantly by industry sector.

Metric ID: net_income_cf

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value-$101.08M-$225.64M-$306.09M-$291.31M-$353.78M-$315.92M-$384.90M-$60.86M-$327.85M-$331.12M$5.07B$0.00$95.30M-$279.92M$118.08M-$252.38M-$223.36M-$166.04M-$313.70M
QoQ Change-123.2%-35.7%+4.8%-21.4%+10.7%-21.8%+84.2%-438.7%-1.0%>999%-100.0%-393.7%+142.2%-313.7%+11.5%+25.7%-88.9%
YoY Change-250.0%-40.0%-25.7%+79.1%+7.3%-4.8%>999%+100.0%+129.1%+15.5%-97.7%-334.4%+40.7%-365.7%
Range-$384.90M$5.07B
CAGR+28.6%
Avg YoY Growth+47.9%
Median YoY Growth+1.3%

Business Segments

View all
SegmentQ3 '25Q4 '25
Reportable Segment-$166.04M-$313.70M
Total-$166.04M-$313.70M

Frequently Asked Questions

What is Roivant Sciences's net income?
Roivant Sciences (ROIV) reported net income of -$313.70M in Q4 2025.
How has Roivant Sciences's net income changed year-over-year?
Roivant Sciences's net income decreased by 365.7% year-over-year, from $118.08M to -$313.70M.
What is the long-term trend for Roivant Sciences's net income?
Over 3 years (2021 to 2024), Roivant Sciences's net income has grown at a -29.9% compound annual growth rate (CAGR), from -$924.12M to -$318.93M.
What does net income mean?
The total profit a company earns after all expenses and taxes are paid.